Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

All Cancer Sites (All Stages^), 2016-2020

Hispanic (any race), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)ยง1


Mississippi6


Alabama6


West Virginia6


Maine6


Vermont6


Virginia6


Arkansas6


Missouri6


District of Columbia6


Maryland6


Ohio6


South Dakota6


Iowa7


Louisiana7


Kentucky7


Tennessee6


South Carolina6


Michigan6


Arizona6


Montana6


Wyoming6


Oklahoma6


California7


North Carolina6


Oregon6


Washington5


Alaska6


Massachusetts7


Nebraska6


New Mexico7


Texas7


Kansas6


Idaho7


Colorado6


New Hampshire6


Illinois7


Delaware6


Florida6


Pennsylvania6


Georgia7


New Jersey7


New York7


Rhode Island6


Utah7


Minnesota6


Connecticut7


Hawaii7


Indiana6 Nevada6 North Dakota6 Puerto Rico6 Wisconsin6

Notes:
Created by statecancerprofiles.cancer.gov on 05/12/2024 7:19 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada, North Dakota, Puerto Rico, Wisconsin

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
¶¶¶ Data for Puerto Rico is only available for All Races (includes Hispanics). For more information see data not available.
§§, §§§ Data not available for this combination of geography, statistic, age, and race/ethnicity.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

NHIA (NAACCR Hispanic Identification Algorithm) was used for Hispanic Ethnicity (see Technical Notes section of the USCS).
Statistics for minorities may be affected by inconsistent race identification between the cancer case reports (sources for numerator of rate) and data from the Census Bureau (source for denominator of rate); and from undercounts of some population groups in the census.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.